Replies to post #173277 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

As the a drug is proved for multiple indications with the same MOA doesn't the burden of proof become less under new FDA protocols?

Will have to look this up later if we don't have anyone here who can expound with authority...